肺癌衍生V-Myc骨髓细胞瘤病毒癌基因同源物1(MYCL1)重组蛋白说明书

Recombinant V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung Carcinoma Derived (MYCL1)

[DESCRIPTION]

Protein Names: V-Myc Myelocytomatosis Viral Oncogene Homolog 1, Lung CarcinomaDerived

Synonyms:MYCL1

Species: Human

Size: 100µg

Source:Escherichia coli-derived

[PROPERTIES]

Residues: Glu257~Tyr394  with N-terminal His-Tag

Grade & Purity: >95%, 17 kDa as determined by SDS-PAGE reducing conditions.

Formulation: Supplied as liquid form in Phosphate buffered saline(PBS), pH 7.4

Endotoxin Level: <1.0 EU per 1μg (determined by the LAL method).

Applications: SDS-PAGE; WB; ELISA; IP.

(May be suitable for use in other assays to be determined by the end user.)

Predicted Molecular Mass: 17.3 kDa

Predicted isoelectric point: 6.7

[PREPARATION]

Reconstitute in sterile PBS, pH7.2-pH7.4.

[STORAGE AND STABILITY]

Storage: Avoid repeated freeze/thaw cycles.

Store at 2-8ºC for one month.

Aliquot and store at -80ºC for 12 months.

Stability Test: The thermal stability is described by the loss rate of the target protein. The loss rate wasdetermined by accelerated thermal degradation test, that is, incubate the protein at 37ºC for 48h, and no obviousdegradation and precipitation were observed. (Referring from China Biological Products Standard, which wascalculated by the Arrhenius equation.) The loss of this protein is less than 5% within the expiration date underappropriate storage condition.

[SEQUENCES]

The target protein is fused with N-terminal His-Tag, its sequence is listed below.MGHHHHHHSGSEF-EASE RGPQEEVLER DAAGEKEDEE DEEIVSPPPV ESEAAQSCHP KPVSSDTEDV TKRKNHNFLERKRRNDLRSR FLALRDQVPT LASCSKAPKV VILSKALEYL QALVGAEKRM ATEKRQLRCR QQQLQKRIAY LSGY

本产品仅供科研使用。不能用于人和动物治疗等其它临床诊断使用